Aridana Sandika, I. M., Sastrawan, M. O., & Arsa Wibawa, N. G. B. (2026). Does Germline BRCA1/2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-analysis of Treatment-Biomarker Interactions. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 10(10), 2896-2908. https://doi.org/10.37275/bsm.v10i10.1658